Insights

Innovative Material Focus AMSilk specializes in high-performance bio-based silk proteins that have applications across multiple industries, including textiles, biomedical, and automotive sectors. This broad material utility suggests opportunities to partner with companies seeking sustainable and advanced materials to enhance product performance and environmental credentials.

Strong Financial backing With recent financing rounds totaling over $60 million and strategic investments from major players like Cargill and Novo Holdings, AMSilk demonstrates robust financial health and growth potential. This indicates a readiness to scale operations and invest in new product development, opening doors for strategic collaborations and large-volume sales.

Strategic Partnerships AMSilk has established collaborations with key industry leaders such as Ajinomoto and Cargill, leveraging expertise in fermentation and bio-manufacturing. These partnerships highlight opportunities for sales engagements with companies involved in industrial fermentation, biotech, or biomanufacturing seeking innovative biomaterials.

Innovation Leadership The company's cutting-edge technologies like DNA edition, protein engineering, and precision fermentation position it as a technological leader in biotech materials. There is potential to target advanced R&D teams and innovation-driven companies looking to incorporate bioengineered solutions into their product lines.

Market Expansion Potential Recent news indicates AMSilk is expanding its operational capabilities and collaborations within Europe and globally, aiming to supply high-performance bio-based materials. This expansion creates opportunities to pitch solutions to multinational corporations seeking sustainable alternatives for their manufacturing processes.

Similar companies to AMSilk GmbH | Biotech Materials

AMSilk GmbH | Biotech Materials Tech Stack

AMSilk GmbH | Biotech Materials uses 8 technology products and services including DATEV, Adobe, Adobe InDesign, and more. Explore AMSilk GmbH | Biotech Materials's tech stack below.

  • DATEV
    Accounting And Finance
  • Adobe
    Audio, Video, Graphics
  • Adobe InDesign
    Cad & Graphics
  • SAP
    Customer Relationship Management
  • JSON-LD
    Javascript Frameworks
  • Lodash
    Javascript Libraries
  • PWA
    Miscellaneous
  • Personio
    Recruitment Marketing

Media & News

AMSilk GmbH | Biotech Materials's Email Address Formats

AMSilk GmbH | Biotech Materials uses at least 1 format(s):
AMSilk GmbH | Biotech Materials Email FormatsExamplePercentage
First.Last@amsilk.comJohn.Doe@amsilk.com
49%
First.MiddleLast@amsilk.comJohn.MichaelDoe@amsilk.com
1%
First.Last@amsilk.comJohn.Doe@amsilk.com
49%
First.MiddleLast@amsilk.comJohn.MichaelDoe@amsilk.com
1%

Frequently Asked Questions

Where is AMSilk GmbH | Biotech Materials's headquarters located?

Minus sign iconPlus sign icon
AMSilk GmbH | Biotech Materials's main headquarters is located at 1-3 Anna-sigmund Straße Neuried, Bavaria 82061 Germany. The company has employees across 2 continents, including EuropeNorth America.

What is AMSilk GmbH | Biotech Materials's official website and social media links?

Minus sign iconPlus sign icon
AMSilk GmbH | Biotech Materials's official website is amsilk.com and has social profiles on LinkedInCrunchbase.

What is AMSilk GmbH | Biotech Materials's SIC code NAICS code?

Minus sign iconPlus sign icon
AMSilk GmbH | Biotech Materials's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does AMSilk GmbH | Biotech Materials have currently?

Minus sign iconPlus sign icon
As of February 2026, AMSilk GmbH | Biotech Materials has approximately 78 employees across 2 continents, including EuropeNorth America. Key team members include Ceo: U. S.Chief Financial Officer: R. F.Chief Production Officer: K. K.. Explore AMSilk GmbH | Biotech Materials's employee directory with LeadIQ.

What industry does AMSilk GmbH | Biotech Materials belong to?

Minus sign iconPlus sign icon
AMSilk GmbH | Biotech Materials operates in the Biotechnology Research industry.

What technology does AMSilk GmbH | Biotech Materials use?

Minus sign iconPlus sign icon
AMSilk GmbH | Biotech Materials's tech stack includes DATEVAdobeAdobe InDesignSAPJSON-LDLodashPWAPersonio.

What is AMSilk GmbH | Biotech Materials's email format?

Minus sign iconPlus sign icon
AMSilk GmbH | Biotech Materials's email format typically follows the pattern of First.Last@amsilk.com. Find more AMSilk GmbH | Biotech Materials email formats with LeadIQ.

How much funding has AMSilk GmbH | Biotech Materials raised to date?

Minus sign iconPlus sign icon
As of February 2026, AMSilk GmbH | Biotech Materials has raised $35M in funding. The last funding round occurred on Sep 09, 2025 for $35M.

When was AMSilk GmbH | Biotech Materials founded?

Minus sign iconPlus sign icon
AMSilk GmbH | Biotech Materials was founded in 2008.

AMSilk GmbH | Biotech Materials

Biotechnology ResearchBavaria, Germany51-200 Employees

AMSilk's Biogenius Materials made from silk proteins are setting new standards in material innovation. Using cutting-edge science and the most advanced technologies like DNA edition, protein engineering and precision fermentation, we transform biogenic materials inspired by nature into groundbreaking Biongenius Materials. At AMSilk, we turn man-made proteins into formulations, including fibers and yarns, hydrogels and silk powder. The high-performance qualities of our material enable a wide range of applications in the textile, homecare, biomedical, and automobile industries and bring breakthrough benefits for products and customers.

Section iconCompany Overview

Headquarters
1-3 Anna-sigmund Straße Neuried, Bavaria 82061 Germany
Website
amsilk.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2008
Employees
51-200

Section iconFunding & Financials

  • $35M

    AMSilk GmbH | Biotech Materials has raised a total of $35M of funding over 6 rounds. Their latest funding round was raised on Sep 09, 2025 in the amount of $35M.

  • $1M$10M

    AMSilk GmbH | Biotech Materials's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $35M

    AMSilk GmbH | Biotech Materials has raised a total of $35M of funding over 6 rounds. Their latest funding round was raised on Sep 09, 2025 in the amount of $35M.

  • $1M$10M

    AMSilk GmbH | Biotech Materials's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.